PVP Ventures Limited — Board Meeting, 20-08-2025: Outcome of Board Meeting
20-08-2025 | 10:34 pm
20-08-2025 | 10:34 pm
PVP Ventures' Q1 consolidated revenue hit ₹17.21 Cr with a net loss of ₹0.11 Cr. The board approved strategic acquisitions of Optimus Oncology and Medilabs. Additionally, it completed a ₹150 Cr NCD fundraising and plans a merger with Humain Healthtech.
No comments yet. Be the first to comment!
